These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 36340306)

  • 1. Management of Alcohol Withdrawal Syndrome in Patients with Alcoholic Liver Disease.
    Chand PK; Panda U; Mahadevan J; Murthy P
    J Clin Exp Hepatol; 2022; 12(6):1527-1534. PubMed ID: 36340306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of Alcohol Use Disorder in Patients With Alcoholic Liver Disease.
    Murthy P; Shadakshari D; Mahadevan J; Chand PK
    J Clin Exp Hepatol; 2022; 12(6):1514-1526. PubMed ID: 36340303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Management of Alcohol Withdrawal Syndrome.
    Ungur AL; Neumann T; Borchers F; Spies C
    Visc Med; 2020 Jun; 36(3):160-166. PubMed ID: 32775345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of alcohol withdrawal syndrome in patients with alcohol-associated liver disease.
    Ratner JA; Blaney H; Rastegar DA
    Hepatol Commun; 2024 Feb; 8(2):. PubMed ID: 38251886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The "Prediction of Alcohol Withdrawal Severity Scale" (PAWSS): systematic literature review and pilot study of a new scale for the prediction of complicated alcohol withdrawal syndrome.
    Maldonado JR; Sher Y; Ashouri JF; Hills-Evans K; Swendsen H; Lolak S; Miller AC
    Alcohol; 2014 Jun; 48(4):375-90. PubMed ID: 24657098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the course and treatment of Alcohol Withdrawal Syndrome with the Clinical Institute Withdrawal Assessment for Alcohol - Revised: A systematic review-based meta-analysis.
    Pribék IK; Kovács I; Kádár BK; Kovács CS; Richman MJ; Janka Z; Andó B; Lázár BA
    Drug Alcohol Depend; 2021 Mar; 220():108536. PubMed ID: 33503582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should the CIWA-Ar be the standard monitoring strategy for alcohol withdrawal syndrome in the intensive care unit?
    Steel TL; Giovanni SP; Katsandres SC; Cohen SM; Stephenson KB; Murray B; Sobeck H; Hough CL; Bradley KA; Williams EC
    Addict Sci Clin Pract; 2021 Mar; 16(1):21. PubMed ID: 33762020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid profile dysregulation predicts alcohol withdrawal symptom severity in individuals with alcohol use disorder.
    Rosoff DB; Charlet K; Jung J; Lee J; Muench C; Luo A; Longley M; Lohoff FW
    Alcohol; 2020 Aug; 86():93-101. PubMed ID: 32335269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fixed-dose gabapentin augmentation in the treatment of alcohol withdrawal syndrome: a retrospective, open-label study.
    Andaluz A; DeMoss D; Claassen C; Blair S; Hsu J; Bakre S; Khan M; Atem F; Rush AJ
    Am J Drug Alcohol Abuse; 2020; 46(1):49-57. PubMed ID: 31490712
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of alcohol-related seizures in withdrawal syndrome.
    Kádár BK; Gajdics J; Pribék IK; Andó B; Lázár BA
    Epilepsia Open; 2024 Apr; 9(2):679-688. PubMed ID: 38279829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Assessment and Treatment of Alcohol Withdrawal Syndrome].
    Choi HY; Seo JS; Lee SK
    Korean J Gastroenterol; 2020 Aug; 76(2):71-77. PubMed ID: 32839369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for alcohol withdrawal-related hospital transfer in a correctional setting.
    Muradian IK; Qureshi N; Singh J; Lin CH; Henderson SO
    Alcohol; 2023 Sep; 111():33-37. PubMed ID: 37119833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the appropriate use of a CIWA-Ar alcohol withdrawal protocol in the general hospital setting.
    Eloma AS; Tucciarone JM; Hayes EM; Bronson BD
    Am J Drug Alcohol Abuse; 2018; 44(4):418-425. PubMed ID: 28981333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Validation Study of the Prediction of Alcohol Withdrawal Severity Scale (PAWSS) in Medically Ill Inpatients: A New Scale for the Prediction of Complicated Alcohol Withdrawal Syndrome.
    Maldonado JR; Sher Y; Das S; Hills-Evans K; Frenklach A; Lolak S; Talley R; Neri E
    Alcohol Alcohol; 2015 Sep; 50(5):509-18. PubMed ID: 25999438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trial.
    Caputo F; Skala K; Mirijello A; Ferrulli A; Walter H; Lesch O; Addolorato G
    CNS Drugs; 2014 Aug; 28(8):743-52. PubMed ID: 24996524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of dexmedetomidine as an adjuvant to benzodiazepine-based therapy to decrease the severity of delirium in alcohol withdrawal in adult intensive care unit patients: a systematic review.
    Woods AD; Giometti R; Weeks SM
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):224-52. PubMed ID: 26447017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic dilemma: alcohol withdrawal syndrome and concurrent hepatic encephalopathy. A case report.
    López A; Chavarría R; Oviedo G
    Rev Colomb Psiquiatr (Engl Ed); 2021; 50(1):52-56. PubMed ID: 33648698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Occurrence, Predictors, and Prognosis of Alcohol Withdrawal Syndrome and Delirium Tremens Following Traumatic Injury.
    Salottolo K; McGuire E; Mains CW; van Doorn EC; Bar-Or D
    Crit Care Med; 2017 May; 45(5):867-874. PubMed ID: 28266937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Dose Gabapentin for the Treatment of Severe Alcohol Withdrawal Syndrome: A Retrospective Cohort Analysis.
    Levine AR; Carrasquillo L; Mueller J; Nounou MI; Naut ER; Ibrahim D
    Pharmacotherapy; 2019 Sep; 39(9):881-888. PubMed ID: 31278761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Gabapentin for Alcohol Withdrawal Syndrome in the Hospital Setting: A Randomized Open-Label Controlled Trial.
    DeFoster RE; Morgan RJ; Leung JG; Schenzel H; Vijapura P; Kashiwagi DT; Fischer KM; Philbrick KL; Kung S
    Subst Use Misuse; 2023; 58(13):1643-1650. PubMed ID: 37469099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.